David J Jollow

Author PubWeight™ 8.02^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.	J Pharmacol Exp Ther	2004	1.22
2	Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.	J Pharmacol Exp Ther	2005	0.96
3	Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.	J Pharmacol Exp Ther	2002	0.93
4	Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents.	Toxicol Sci	2005	0.87
5	Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.	J Pharmacol Exp Ther	2002	0.84
6	Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.	J Pharmacol Exp Ther	2005	0.84
7	Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol.	Environ Health Perspect	2006	0.81
8	Role of oxidant stress in lawsone-induced hemolytic anemia.	Toxicol Sci	2004	0.81
9	Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates.	Toxicology	2004	0.76